Ananda Devices’ technology enables 50x faster and 90x more cost-effective evaluation
of toxicity and efficacy of medications, cosmetics, and pesticides before contact with
humans. We help biopharmaceutical companies comply with legislation to reduce animal
experimentation and launch safer products to humans. Our products include organon-
a-chip devices to automate safety and efficacy analysis of compounds on models
of the human brain, spinal cord and innervated tissues. We also offer services to help
biopharmaceutical companies increase automation of specific assays such as developing
models of Parkinson-on-a-chip and Autism-on-a-chip.
